Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
about
sameAs
Thrombolysis for acute ischaemic strokeSonothrombolysis for acute ischaemic strokeSonothrombolysis for acute ischaemic strokeThrombolysis for acute ischaemic strokeSonothrombolysis for acute ischaemic strokeThrombolysis for acute ischaemic strokeAbsolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS).Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery.Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional SurgeryCurrent perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeNeuroimaging of cerebral ischemia and infarctionImaging of acute ischemic stroke.MRI blood-brain barrier permeability measurements to predict hemorrhagic transformation in a rat model of ischemic stroke.Selection of possible responders to thrombolytic therapy in acute ischemic stroke.Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes.Thrombolysis in acute ischemic stroke: successes, failures, and new hopes.Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry (CNSR).Modern imaging of the infarct core and the ischemic penumbra in acute stroke patients: CT versus MRI.Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional NeurologyCombination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia.The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm.Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.Imaging and treatment of patients with acute stroke: an evidence-based review.Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review.Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.Clinical factors in patients with ischemic versus hemorrhagic stroke in East China.Relationship of neurovascular elements to neuron injury during ischemia.How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.Recombinant tissue plasminogen activators (rtPA): a review.Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts.Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.The response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model.Hemorrhagic transformation of childhood arterial ischemic stroke.Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke.Development of thrombolytic therapy for stroke: a perspective.
P2860
Q24194788-609E1564-06E7-4F90-97F6-DE716A61F6CFQ24198052-EA703721-215D-4892-8719-49CE45DCE056Q24202717-EADF2868-3168-448C-8EDC-23806ACD6276Q24240067-252B7C52-7619-45FA-986A-765334E9C59CQ24240222-D7026F16-7280-46C4-8164-B7ECF9CFCCD4Q24247962-06177855-7D9C-4410-BB87-16F931D39B9DQ26796474-33B38324-19CE-4CAF-9C8D-6B62AC3002EBQ30370528-0545D8A4-6485-4BF8-BA63-1E749A7F4873Q30407045-C5CFD7B9-D5DA-4F10-B7EE-A016198EE901Q30409698-73CE082B-3B62-4C7D-BEA1-FB7C0CDE96B8Q30411178-C446F01C-E505-4536-BDA9-CF44ADCD04FFQ30414441-F2F76BC0-B8F6-4432-AFDC-EEC918BD7E58Q30428970-B939D377-7ACC-4BB6-BF10-4EFE0B079B4AQ30430085-7D2A2BB1-4952-4F54-8BC9-697A547FA3CFQ30457216-4FAC321E-38AA-48F2-95B7-2D68D6159D5AQ30568984-A37B938F-6020-4E0F-9D1D-77132EDAFE2AQ30573815-779CBF78-4F66-4945-917C-5ECEEC68EDC1Q31023327-BD97BE8F-2ED6-471D-8892-8B4999D9860EQ31109008-DCEE1919-B428-451D-BC83-380228E711B0Q33432257-42D1507F-936E-4023-A104-79DD6E3AC3C4Q33610598-DF120508-D392-4936-8BCA-0B10C97E1190Q33735191-30C481EA-0879-4877-AD38-F899771D2F64Q33814642-EF4CBD15-4ACC-4756-B1CA-F401B5E4176DQ33853254-5D755A19-FBD5-424B-BBAD-77C6F71F9B8BQ33888222-1A8E7A92-7FCC-4666-A7A6-21EFE74FDD29Q33926874-F963F55F-AFC4-4E8E-9C88-BFBEBAF18AD2Q33940129-A5B31DDB-9243-47A2-B1AF-E35B090EA46BQ33978307-E634FE79-FBF2-493F-A89A-504DFEBD80EFQ33978760-8937F7E8-0227-43FF-A139-600D947FA245Q34006140-ACB945DC-49FF-40A9-AD0B-6537FFA4A6A4Q34031908-2EB03407-E1E4-47CB-828D-04A30E0D4ED1Q34038281-74BF7A53-1C5C-4818-9AEB-F43A4E881DC7Q34418517-2C6B9315-896D-4737-B969-E18C2977F349Q34462146-7FE56C25-218D-4D10-931F-94CB6874730FQ34554231-64AA1ADF-E38C-4CE7-BE58-B5D2ACA35BD2Q34566668-C5BA3B10-E25F-4551-9835-1334D182373CQ34652071-A00582B1-C7C9-4FCB-93E3-931F9A24585AQ34733418-72B37D4E-DF0D-4985-BC46-806CC4795BB8Q34992765-4BA8EF6E-C475-4A01-9240-EE989CD9BA9BQ35001038-7C70ED2B-A551-40CD-800C-5C567CCF4F5A
P2860
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@ast
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@en
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@nl
type
label
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@ast
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@en
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@nl
prefLabel
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@ast
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@en
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@nl
P2093
P3181
P356
P1433
P1476
Risk factors for severe hemorr ...... Acute Stroke Study (ECASS II)
@en
P2093
R von Kummer R
P304
P3181
P356
10.1161/01.STR.32.2.438
P407
P577
2001-02-01T00:00:00Z